Haruyasu Murakami

K-3 VLBI software development for international experiments

Tetsuro Kondo, Hiroo Kunimori, Fujinobu Takahashi, 1982 .

Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors

Makoto Nishio, Haruyasu Murakami, Takashi Seto, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Impact of Clinical Outcomes According to EGFR Mutation Status in Patients with Locally Advanced Lung Adenocarcinoma Who Recieved Concurrent Chemoradiotherapy

Masahiro Endo, Takashi Nakajima, Akira Ono, 2014, American journal of clinical oncology.

Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System

Akira Ono, Haruyasu Murakami, Takehito Shukuya, 2013, PloS one.

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study

Masahiro Endo, Takashi Nakajima, Akira Ono, 2013, BMC Cancer.

Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors

Haruyasu Murakami, Noboru Yamamoto, H. Kenmotsu, 2016, Investigational New Drugs.

Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer

Masahiro Endo, Akira Ono, Haruyasu Murakami, 2015, Supportive Care in Cancer.